BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22962412)

  • 1. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype.
    Carrero JJ; Stenvinkel P
    Nephrol Dial Transplant; 2012 Nov; 27(11):4030-41. PubMed ID: 22962412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
    Carrero JJ; Bárány P; Yilmaz MI; Qureshi AR; Sonmez A; Heimbürger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2012 Feb; 27(2):709-15. PubMed ID: 21617198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options.
    Iglesias P; Carrero JJ; Díez JJ
    J Nephrol; 2012; 25(1):31-42. PubMed ID: 21748720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in fertility and hormone replacement therapy in kidney disease.
    Holley JL; Schmidt RJ
    Adv Chronic Kidney Dis; 2013 May; 20(3):240-5. PubMed ID: 23928388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypogonadism in men with chronic kidney disease.
    Johansen KL
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):348-56. PubMed ID: 15492971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone deficiency in older men: a problem worth treating.
    McHenry Martin C
    Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between uremic hypogonadism and zinc?
    Mahajan SK; Abbasi AA; Prasad AS; Briggs WA; McDonald FD
    Proc Clin Dial Transplant Forum; 1979; 9():165-9. PubMed ID: 121812
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS
    Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy for the primary care physician.
    Casey RW; Barkin J
    Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of hypogonadism in adult males].
    Köhn FM
    Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement in older men and women.
    Morley JE
    J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical hypogonadism and androgen replacement therapy: an overview.
    Ohl DA; Quallich SA
    Urol Nurs; 2006 Aug; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function in chronic kidney disease.
    Anantharaman P; Schmidt RJ
    Adv Chronic Kidney Dis; 2007 Apr; 14(2):119-25. PubMed ID: 17395114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
    Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA
    Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848
    [No Abstract]   [Full Text] [Related]  

  • 20. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.